165 related articles for article (PubMed ID: 2322591)
1. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.
Veldscholte J; Voorhorst-Ogink MM; Bolt-de Vries J; van Rooij HC; Trapman J; Mulder E
Biochim Biophys Acta; 1990 Apr; 1052(1):187-94. PubMed ID: 2322591
[TBL] [Abstract][Full Text] [Related]
2. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
Montgomery BT; Young CY; Bilhartz DL; Andrews PE; Prescott JL; Thompson NF; Tindall DJ
Prostate; 1992; 21(1):63-73. PubMed ID: 1379363
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP.
Schuurmans AL; Bolt J; Mulder E
Urol Int; 1989; 44(2):71-6. PubMed ID: 2728128
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.
Veldscholte J; Ris-Stalpers C; Kuiper GG; Jenster G; Berrevoets C; Claassen E; van Rooij HC; Trapman J; Brinkmann AO; Mulder E
Biochem Biophys Res Commun; 1990 Dec; 173(2):534-40. PubMed ID: 2260966
[TBL] [Abstract][Full Text] [Related]
5. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids.
Schuurmans AL; Bolt J; Voorhorst MM; Blankenstein RA; Mulder E
Int J Cancer; 1988 Dec; 42(6):917-22. PubMed ID: 3263955
[TBL] [Abstract][Full Text] [Related]
6. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.
Veldscholte J; Berrevoets CA; Ris-Stalpers C; Kuiper GG; Jenster G; Trapman J; Brinkmann AO; Mulder E
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):665-9. PubMed ID: 1562539
[TBL] [Abstract][Full Text] [Related]
7. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
Beilin J; Ball EM; Favaloro JM; Zajac JD
J Mol Endocrinol; 2000 Aug; 25(1):85-96. PubMed ID: 10915221
[TBL] [Abstract][Full Text] [Related]
8. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
Berns EM; de Boer W; Mulder E
Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
[TBL] [Abstract][Full Text] [Related]
9. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
10. Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor.
Grigoryev DN; Long BJ; Njar VC; Brodie AH
J Steroid Biochem Mol Biol; 2000 Dec; 75(1):1-10. PubMed ID: 11179903
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
Michel G; Baulieu EE
Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
[TBL] [Abstract][Full Text] [Related]
13. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
[TBL] [Abstract][Full Text] [Related]
14. Binding of progestagens to receptor proteins in MCF-7 cells.
Bergink EW; van Meel F; Turpijn EW; van der Vies J
J Steroid Biochem; 1983 Nov; 19(5):1563-70. PubMed ID: 6645495
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of androgen receptor by nonandrogenic steroids.
Nemoto T; Ohara-Nemoto Y; Sato M; Ota M
Biochem Int; 1986 May; 12(5):701-5. PubMed ID: 3488063
[TBL] [Abstract][Full Text] [Related]
16. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.
Castagnetta LA; Miceli MD; Sorci CM; Pfeffer U; Farruggio R; Oliveri G; CalabrĂ² M; Carruba G
Endocrinology; 1995 May; 136(5):2309-19. PubMed ID: 7536668
[TBL] [Abstract][Full Text] [Related]
17. Threonine on amino acid position 868 in the human androgen receptor is essential for androgen binding specificity and functional activity.
Ris-Stalpers C; Verleun-Mooijman MC; Trapman J; Brinkmann AO
Biochem Biophys Res Commun; 1993 Oct; 196(1):173-80. PubMed ID: 8216289
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the cytosol androgen receptor of the human prostate.
Wilbert DM; Griffin JE; Wilson JD
J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
[TBL] [Abstract][Full Text] [Related]
20. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP.
Langeler EG; van Uffelen CJ; Blankenstein MA; van Steenbrugge GJ; Mulder E
Prostate; 1993; 23(3):213-23. PubMed ID: 7694266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]